| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/24/2023 | 28.9% | Wolfe Research | $113 → $116 | Maintains | Outperform |
| 10/04/2023 | — | Wolfe Research | Upgrades | Peer Perform → Outperform | |
| 08/02/2023 | 0.01% | Stifel | $86 → $90 | Maintains | Hold |
| 08/02/2023 | 22.24% | Stephens & Co. | $73 → $110 | Maintains | Equal-Weight |
| 07/21/2023 | -18.88% | Stephens & Co. | → $73 | Reiterates | Equal-Weight → Equal-Weight |
| 05/05/2023 | -18.88% | Stephens & Co. | $70 → $73 | Maintains | Equal-Weight |
| 04/20/2023 | -22.21% | Stifel | $73 → $70 | Maintains | Hold |
| 02/22/2023 | -22.21% | Stephens & Co. | $75 → $70 | Maintains | Equal-Weight |
| 01/19/2023 | -18.88% | Stifel | $79 → $73 | Maintains | Hold |
| 11/17/2022 | — | Wolfe Research | Upgrades | Underperform → Peer Perform | |
| 11/03/2022 | 0.01% | Stephens & Co. | $105 → $90 | Maintains | Equal-Weight |
| 08/16/2022 | -11.1% | Wolfe Research | → $80 | Initiates Coverage On | → Underperform |
| 08/02/2022 | 3.34% | Stifel | $131 → $93 | Downgrades | Buy → Hold |
| 03/14/2022 | 45.57% | Stifel | $98 → $131 | Maintains | Buy |
| 02/18/2022 | 16.68% | Stephens & Co. | $95 → $105 | Maintains | Equal-Weight |
| 10/12/2021 | 2.23% | Stifel | $80 → $92 | Maintains | Buy |
| 04/29/2021 | -22.21% | Stephens & Co. | → $70 | Downgrades | Overweight → Equal-Weight |
| 02/24/2021 | -11.1% | Stephens & Co. | $70 → $80 | Maintains | Overweight |
| 11/03/2020 | -22.21% | Stephens & Co. | → $70 | Upgrades | Equal-Weight → Overweight |
| 10/09/2020 | -33.33% | Sidoti & Co. | $50 → $60 | Maintains | Buy |
| 08/06/2020 | -49.99% | Stifel | $44 → $45 | Maintains | Buy |
| 04/06/2020 | — | Stephens & Co. | Downgrades | Overweight → Equal-Weight | |
| 02/25/2020 | — | Stifel | Upgrades | Hold → Buy | |
| 12/20/2019 | -46.66% | Sidoti & Co. | $45 → $48 | Maintains | Buy |
| 02/25/2019 | -51.11% | Stephens & Co. | $40 → $44 | Upgrades | Equal-Weight → Overweight |
| 11/20/2018 | — | Stifel | Downgrades | Buy → Hold |
What is the target price for Matson (MATX)?
The latest price target for Matson (NYSE: MATX) was reported by Wolfe Research on October 24, 2023. The analyst firm set a price target for $116.00 expecting MATX to rise to within 12 months (a possible 28.90% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Matson (MATX)?
The latest analyst rating for Matson (NYSE: MATX) was provided by Wolfe Research, and Matson maintained their outperform rating.
When is the next analyst rating going to be posted or updated for Matson (MATX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Matson, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Matson was filed on October 24, 2023 so you should expect the next rating to be made available sometime around October 24, 2024.
Is the Analyst Rating Matson (MATX) correct?
While ratings are subjective and will change, the latest Matson (MATX) rating was a maintained with a price target of $113.00 to $116.00. The current price Matson (MATX) is trading at is $89.99, which is out of the analyst's predicted range.